Answer
Yes, hypersensitivity to decitabine or any excipient listed in section 6.1 is a contraindication to Dacogen treatment.
Sources for this answer
- Dacogen 50 mg powder for concentrate for solution for infusion.(Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 16Document updated
Sources checked